5-fluoro-4-methoxypyrimidine-2-carboxylic acid

5-fluoro-4-methoxypyrimidine-2-carboxylic acid Struktur
1545825-63-5
CAS-Nr.
1545825-63-5
Englisch Name:
5-fluoro-4-methoxypyrimidine-2-carboxylic acid
Synonyma:
5-fluoro-4-methoxypyrimidine-2-carboxylic acid;5-Fluoro-4-methoxy-2-pyrimidinecarboxylic acid;2-Pyrimidinecarboxylic acid, 5-fluoro-4-methoxy-
CBNumber:
CB14847712
Summenformel:
C6H5FN2O3
Molgewicht:
172.11
MOL-Datei:
1545825-63-5.mol

5-fluoro-4-methoxypyrimidine-2-carboxylic acid Eigenschaften

Siedepunkt:
402.4±48.0 °C(Predicted)
Dichte
1.475±0.06 g/cm3(Predicted)
pka
2.90±0.10(Predicted)

Sicherheit

5-fluoro-4-methoxypyrimidine-2-carboxylic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

5-fluoro-4-methoxypyrimidine-2-carboxylic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


5-fluoro-4-methoxypyrimidine-2-carboxylic acid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 8)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ShangHai Wisacheam Pharmaceutical Co., Ltd. 13817485796
tim@wisacheampharm.com China 3802 58
Birdo (Shanghai) Medical Technology Co., Ltd. 021-021-021-021-58099077-8102-8041-8041-8041 18601625411
sales@birdotech.com China 9421 58
Taizhou Nanfeng Pharmaceutical Research Institute 18616377689
nanfengdrug@163.com China 20566 58
Bide Pharmatech Ltd. 400-1647117 13681763483
product02@bidepharm.com China 62163 58
Shanghai Haohong Scientific Co., Ltd. 400-400-8210725
malulu@leyan.com China 39990 58
Xi'an Ruicheng Pharmaceutical Technology Co., Ltd 17791728244 17791728244
3356623179@qq.com China 879 58
Shaanxi kelkai Pharmaceutical Technology Co., Ltd 029-029-2148545164 17392779578
2148545164@qq.com China 4566 58
Beijing Famozi Pharmaceutical Technology Co., Ltd 13331045123
2728639891@qq.com China 9244 58

  • 5-fluoro-4-methoxypyrimidine-2-carboxylic acid
  • 2-Pyrimidinecarboxylic acid, 5-fluoro-4-methoxy-
  • 5-Fluoro-4-methoxy-2-pyrimidinecarboxylic acid
  • 1545825-63-5
Copyright 2019 © ChemicalBook. All rights reserved